Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | HPGD | P15428 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 3/20 | 0.71 |
| ▸ | GLA | P06280 | 2/20 | 0.71 |
| ▸ | ACHE | P22303 | 1/20 | 0.71 |
| ▸ | HTR3A | P46098 | 1/20 | 0.52 |
| ▸ | NQO2 | P16083 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.45 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | STAT3 | P40763 | 1/20 | 0.42 |
| ▸ | IKBKB | O14920 | 1/20 | 0.41 |
| ▸ | PDE2A | O00408 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acridine SCHEMBL4972293 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL8339 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL1772714 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL3045498 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL29352289 | 0.84 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL28830169 | 0.82 | MAPT (0.83) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL618814 | 0.82 | ALDH1A1 (0.94) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL10801271 | 0.82 | ALDH1A1 (0.94) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL5182487 | 0.82 | ALDH1A1 (0.94) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL641951 | 0.82 | ALDH1A1 (0.94) | ALDH1A1HPGDMAPTGLAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110487777-A | The method that acridinium ester chemiluminescent detects HLA-G prediction pre-eclampsia | SHAOXING KANGYUE BIOLOGICAL TECH CO LTD | 2019-11-22 | — | — | CN | claimed |
| CN-110058028-A | A kind of bis- hydroxy-vitamine D immunity detection reagents of 24,25- and its application | 苏州长光华医生物医学工程有限公司 | 2019-07-26 | — | — | CN | claimed |
| CN-109283171-A | A kind of screening technique of chemical illuminating reagent stabilizer | 苏州长光华医生物医学工程有限公司 | 2019-01-29 | — | — | CN | claimed |
| CN-108344869-A | A kind of hepatitis B surface antigen chemiluminescence immune detection reagent kit and its application | 苏州长光华医生物医学工程有限公司 | 2018-07-31 | — | — | CN | claimed |
| CN-105264377-B | Degradable cationic surface active agent and its purposes in enhanced chemiluminescence | 西门子医疗保健诊断公司 | 2017-09-08 | — | — | CN | claimed |
| EP-1358344-B1 | Dendritic chemiluminescent substrates | APPLERA CORP (US) | 2007-08-29 | — | — | EP | claimed |
| US-20070184491-A1 | Dendritic chemiluminescent substrates | APPLIED BIOSYSTEMS, INC. | 2007-08-09 | — | — | US | claimed |
| EP-1049933-B1 | MEASUREMENT OF HYDRIDE USING CHEMILUMINESCENT ACRIDINIUM COMPOUNDS | BAYER AG (US) | 2005-09-14 | — | — | EP | claimed |
| EP-1358344-A4 | DENDRITIC CHEMILUMINESCENT SUBSTRATES | APPLERA CORP (US) | 2004-11-03 | — | — | EP | claimed |
| US-6673560-B1 | USE IN DETECTION OF METAL HYDRIDES, ENZYME COFACTORS OR DIAGNOSTIC/MEDICAL DIAGNOSTIC ASSAYS USING DEHYDROGENASES AS REAGENTS, INDICATORS, MARKERS, OR LABELS | BAYER CORPORATION | 2004-01-06 | — | — | US | claimed |
| EP-1358344-A2 | Dendritic chemiluminescent substrates | TROPIX, INC. (US) | 2003-11-05 | — | — | EP | claimed |
| US-20020155523-A1 | Chemiluminescent substrate for use as diagnostic tool in analysis of macromolecules | APPLIED BIOSYSTEMS, INC. | 2002-10-24 | — | — | US | claimed |
| WO-2002057745-A2 | DENDRITIC CHEMILUMINESCENT SUBSTRATES | TROPIX, INC. (US) | 2002-07-25 | — | — | WO | claimed |
| EP-1049933-A1 | MEASUREMENT OF HYDRIDE USING CHEMILUMINESCENT ACRIDINIUM COMPOUNDS | Bayer Corporation (US) | 2000-11-08 | — | — | EP | claimed |
| WO-2000031543-A1 | MEASUREMENT OF HYDRIDE USING CHEMILUMINESCENT ACRIDINIUM COMPOUNDS | BAYER CORPORATION (US) | 2000-06-02 | — | — | WO | claimed |
| CN-112986221-B | Method for detecting object to be detected in sample and kit thereof | 利多(香港)有限公司 | 2024-10-22 | — | — | CN | disclosed |
| CN-110487777-A | The method that acridinium ester chemiluminescent detects HLA-G prediction pre-eclampsia | SHAOXING KANGYUE BIOLOGICAL TECH CO LTD | 2019-11-22 | — | — | CN | disclosed |
| EP-0273115-B1 | Chemiluminescent acridinium and phenanthridinium salts | ABBOTT LAB (US) | 1994-09-07 | — | — | EP | disclosed |
| EP-0273115-A2 | Chemiluminescent acridinium and phenanthridinium salts | ABBOTT LABORATORIES (US) | 1988-07-06 | — | — | EP | disclosed |
| EP-0273115-A2 | Chemiluminescent acridinium and phenanthridinium salts | ABBOTT LABORATORIES (US) | 1988-07-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020155523-A1 | Chemiluminescent substrate for use as diagnostic tool in analysis of macromolecules | LPO, DCLRE1B, LIG3 | ALDH1A1 1047/4885HPGD 420/4885MAPT 3490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.